Back to User profile » Dr Josep Maria Haro

Papers published by Dr Josep Maria Haro:


Correlation of Health-Related Quality of Life in Clinically Stable Outpatients with Schizophrenia

Domenech C, Pastore A, Altamura AC, Bernasconi C, Corral R, Elkis H, Evans J, Malla A, Margari F, Krebs MO, Nordstroem AL, Zink M, Haro JM

Neuropsychiatric Disease and Treatment 2019, 15:3475-3486

Published Date: 20 December 2019

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline

Huang J, Wang Y, Chen J, Zhang Y, Yuan Z, Yue L, Haro JM, Moneta MV, Novick D, Fang YR

Neuropsychiatric Disease and Treatment 2018, 14:2473-2484

Published Date: 26 September 2018

The use of random-effects models to identify health care center-related characteristics modifying the effect of antipsychotic drugs

Nordon C, Battin C, Verdoux H, Haro JM, Belger M, Abenhaim L, van Staa TP

Clinical Epidemiology 2017, 9:689-698

Published Date: 14 December 2017

Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study

Novick D, Montgomery W, Vorstenbosch E, Moneta MV, Dueñas H, Haro JM

Patient Preference and Adherence 2017, 11:1859-1868

Published Date: 31 October 2017

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder

Novick D, Montgomery W, Treuer T, Koyanagi A, Aguado J, Kraemer S, Haro JM

Patient Preference and Adherence 2017, 11:1019-1025

Published Date: 6 June 2017

Sex differences in the course of schizophrenia across diverse regions of the world

Novick D, Montgomery W, Treuer T, Moneta MV, Haro JM

Neuropsychiatric Disease and Treatment 2016, 12:2927-2939

Published Date: 14 November 2016

Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients

Novick D, Montgomery W, Aguado J, Peng XM, Haro JM

Neuropsychiatric Disease and Treatment 2016, 12:795-800

Published Date: 11 April 2016

Antidepressant medication treatment patterns in Asian patients with major depressive disorder

Novick D, Montgomery W, Moneta V, Peng X, Brugnoli R, Haro JM

Patient Preference and Adherence 2015, 9:421-428

Published Date: 11 March 2015

Towards Horizon 2020: challenges and advances for clinical mental health research – outcome of an expert survey

van der Feltz-Cornelis CM, van Os J, Knappe S, Schumann G, Vieta E, Wittchen HU, Lewis SW, Elfeddali I, Wahlbeck K, Linszen D, Obradors-Tarragó C, Haro JM

Neuropsychiatric Disease and Treatment 2014, 10:1057-1068

Published Date: 27 June 2014

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection

Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H

Neuropsychiatric Disease and Treatment 2014, 10:1125-1131

Published Date: 20 June 2014

Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?

Novick D, Montgomery W, Kadziola Z, Moneta V, Peng X, Brugnoli R, Haro JM

Patient Preference and Adherence 2013, 7:463-470

Published Date: 27 May 2013